Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Susan Krege"'
Autor:
Aristotle Bamias, Guru Sonpavde, Amanda Leiter, Matthew D. Galsky, Chia-Chia Lin, Noah M. Hahn, William Oh, John Doucette, Susan Krege, Thorsten H. Ecke
Publikováno v:
Bladder Cancer
Background: Obesity has been associated with worse outcomes in patients with clinically localized urothelial cancer. However, this impact has not been evaluated in metastatic disease. Objective: To assess the impact of obesity on outcomes of patients
Autor:
Susan Krege, Noah M. Hahn, James Godbold, Erin Moshier, Matthew D. Galsky, Aristotle Bamias, Chia-Chi Lin, Thorsten Ecke, Guru Sonpavde, William Oh
Publikováno v:
Cancer. 119:3012-3019
BACKGROUND The current study was conducted to develop a pretreatment prognostic model for patients with unresectable and/or metastatic urothelial cancer who were treated with first-line, cisplatin-based chemotherapy. METHODS Individual data were pool
Autor:
William Oh, Chia-Chi Lin, Guru Sonpavde, Matthew D. Galsky, James Godbold, Aristotle Bamias, Noah M. Hahn, Susan Krege, Erin Moshier, Thorsten H. Ecke, Gregory R. Pond
Publikováno v:
Urologic oncology. 32(1)
Background Models to predict the outcome of patients with metastatic urothelial cancer (UC), based on pretreatment variables, have previously been developed. However, patients often request “updated” prognostic estimates based upon their response
Autor:
Matthew D, Galsky, Susan, Krege, Chia-Chi, Lin, Noah, Hahn, Thorsten, Ecke, Erin, Moshier, Guru, Sonpavde, James, Godbold, William K, Oh, Aristotle, Bamias
Publikováno v:
Cancer. 119(16)
Use of progression-free survival (PFS) as a clinical trial endpoint in first-line treatment of patients with metastatic urothelial carcinoma (UC) is attractive, but would be enhanced by establishing a correlation between PFS and overall survival (OS)
Autor:
Guru Sonpavde, Susan Krege, Erin Moshier, Matthew D. Galsky, William Oh, Chia-Chi Lin, Thorsten Ecke, James Godbold, Aristotle Bamias, Noah M. Hahn, Lindsay Haines
Publikováno v:
Clinical genitourinary cancer. 11(3)
Background Although urothelial cancer is more common in men, women with urothelial cancer have inferior survival outcomes. The potential existence of gender-related disparities in patients with metastatic urothelial cancer has not been extensively ex
Autor:
Matthew D. Galsky, Guru Sonpavde, Susan Krege, James Godbold, Erin Moshier, Thorsten H. Ecke, Noah M. Hahn, Aristotle Bamias, William Oh, Chia-Chi Lin
Publikováno v:
Urologic oncology. 32(1)
Purpose Cisplatin-based chemotherapy is standard first-line treatment for metastatic urothelial carcinoma. However, cisplatin is frequently avoided in elderly patients due to concerns regarding toxicities. We analyzed the efficacy, and tolerability,
Autor:
Craig R. Nichols, Peter Albers, Lori Wood, Christian Kollmannsberger, Axel Heidenreich, Susan Krege, Sophie D. Fosså, Jan Oldenburg, Siamak Daneshmand
Publikováno v:
European urology. 62(5)
Some controversy still exists regarding the management of testis cancer following chemotherapy for disseminated disease.To review the available literature concerning the management of postchemotherapy testis cancer.A Medline search was conducted to i